Calcium acetate/magnesium carbonate

Calcium acetate/magnesium carbonate is a fixed-dose combination drug that contains 110 mg calcium and 60 mg magnesium ions and is indicated as a phosphate binder for dialysis patients suffering from hyperphosphataemia (abnormal high serum phosphorus levels). It is registered by Fresenius Medical Care under the trade names Renepho (Belgium) and OsvaRen (a number of other European countries).

Calcium acetate/magnesium carbonate

Calcium acetate/magnesium carbonate is a fixed-dose combination drug that contains 110 mg calcium and 60 mg magnesium ions and is indicated as a phosphate binder for dialysis patients suffering from hyperphosphataemia (abnormal high serum phosphorus levels). It is registered by Fresenius Medical Care under the trade names Renepho (Belgium) and OsvaRen (a number of other European countries).